Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995 - Couverture souple

Galambos, Louis

Couverture souple

ISBN 10 : 052162620X ISBN 13 : 9780521626200

Editeur : Cambridge University Press, 1997

Synopsis

How private organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market antitoxins and vaccines.

A propos du livre

Présentation de l'éditeur

Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.

Revue de presse

'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal

Détails de l'édition

• Éditeur: Cambridge University Press
• Date d'édition: 1997
• Langue: anglais
• ISBN 10: 052162620X
• ISBN 13: 9780521626200
• Reliure: Broché
• Nombre de pages: 288
• Coordonnées du fabricant: non disponible
• Personne responsable: Avery; https://www.avery.fr/; ; chemin des peupliers 27; Dardilly; France